baber/WOPTO huggingface dataset:
Patent FI-970308-A0 (FI)
Inventor: WALLDEN LARS
IPC: E05B15/08
Filed: 1997-01-24
Abstract: PCT No. PCT/SE95/00886 Sec. 371 Date Jan. 28, 1997 Sec. 102(e) Date Jan. 28, 1997 PCT Filed Jul. 26, 1995 PCT Pub. No. WO96/03562 PCT Pub. Date Feb. 8, 1996A cylinder lock/key combination includes a lock cylinder (2), a plug (3) rotatably mounted in the cylinder (2) and having a key slot (4), and a number of tumbler pins (6) that are activatable by the code (5a) on the key (5). The key slot carries or houses an element (7) which extends axially along a substantial part of the slot. The key (5) has a blade part (5c) which includes an axially extending portion (5d) in which there is provided a hole (8) for receiving the slot-carried element (7) as the key is inserted into the lock. The slot-carried element (7) and the hole (8) provided in the key (5) are located eccentrically in relation to the center of the plug (3) and accompany rotation of the plug while aided by the key (5). The profile shape of the slot-carried element (7) and the hole (8) in the key may vary within wide limits. The invention also relates to a key belonging to a combination of the aforementioned kind, and to a key blank from which such a key can be produced.
Patent FI-972591-A0 (FI)
Inventor: LINKOLA JANNE
IPC: H04W4/24
Filed: 1997-06-17
Abstract: Rate charging rules and principles concerning mobile calls in a cellular communication system can be improved by providing the mobile station with a locator object which, at certain intervals, determines the cell in which the mobile station is currently located. Stored in the mobile station is a list of cells or areas in which a special rate is to be applied in charging for calls originating from the mobile station. The locator object monitors calls made from the mobile station and, when it detects that a call is being made, it determines whether the mobile station was in a denoted special rate area at the time that its location was most recently determined. If so, then the object informs the network that the call is entitled to the special rate. Since the last location function was executed just before call setup commenced, a special rate call is possible even if the mobile station has thereafter moved some distance into a cell applying a normal rate. Disposed in a billing center is a billing object, to which the locator object sends data indicating whether the call was initiated from a cell or area in which a special rate is applicable, as well as data identifying the particular call. The second object receives the billing records generated by the mobile switching center, which also contain call identifying data, and compares the call-specific data in those records with the data sent by the first object. In this way, the second object can identify from the billing records those calls that are entitled to a special rate, regardless of whether the mobile station has moved during call setup from the original cell into a cell where another rate, e.g. a higher rate, is applicable.
Patent FI-973291-A0 (FI)
Inventor: LOENNOE ANDERS
IPC: B29B11/16
Filed: 1997-08-11
Abstract: PCT No. PCT/SE96/00187 Sec. 371 Date Aug. 13, 1997 Sec. 102(e) Date Aug. 13, 1997 PCT Filed Feb. 13, 1996 PCT Pub. No. WO96/25655 PCT Pub. Date Aug. 22, 1996The invention relates to a device for obtaining, in the manufacture of a high-strength composite, an indication the reinforcement layer of the composite has been wetted throughout by the matrix material of the composite. The reinforcement layer is of the type which mainly consists of fibers or fiber bundles which do not become translucent or transparent when wetted by the matrix material, such as carbon or aramide fibers or fiber bundles. The matrix material of thermosetting plastic is applied in a liquid state in the manufacture according to, for instance, the technique of hand lay-up. The reinforcement layer includes indicating fibers which become translucent or transparent when wetted by the matrix material. A good indication is obtained if the indicating fibers have such properties that they become translucent only when the adjoining reinforcing material has been completely wetted throughout. Preferably the indicating fibres are uniformly distributed across the reinforcement layer and in an amount that does not affect the properties of the composite significantly.
Patent FI-981073-A0 (FI)
Inventor: STEPHAN DOUGLAS W
IPC: C08F4/642
Filed: 1998-05-14
Abstract: A solution process for the preparation of high molecular weight ethylene copolymers comprising contacting olefin monomers, with a catalyst system at a polymerization temperature at or above about 80 DEG C with a catalyst system comprising an unbridged Group 4 metal compound having a monocyclopentadienyl ligand, a phospihinimine ligand and at least one uninegative, activation reactive ligand. The process can be practised at a reaction temperature of at least 80 DEG C to obtain high number average molecular weight polymer.
Patent AP-9901604-A0 (AP)
Title: Paroxetine compositions.
Inventor: JACEWICZ VICTOR WITOLD
IPC: A61K9/16
Filed: 1998-01-12
Abstract: Paroxetine hydrochloride is obtained in a free-flowing and easily soluble form (suitable for preparing solid formulaltions or aqueous solutions, suitable for parenteral use)by spray-drying solutions of paroxetine hydrochloride hemihydrate or other anhydrate/hydrate/solvate/amorphous forms.
Patent AP-9901606-A0 (AP)
Title: Biological tissue stimulation by optical energy.
Inventor: BELLINGER GARY J
IPC: A61B18/20
Filed: 1998-01-09
Abstract: Biological tissue of a living subject is irradiated with optical energy at a wavelength and at a power dissalipation level to cause the amount of optical energy absorbed and converted to heat in the tissue to be within a range bounded by a minimum absorption rate sufficient to elevate the average temperature of the irradiated tissue to a level above the basal body temperature, but which is less than the absorption rate at which tissue is converted into a collagenous substance. According to this method, a therapeutic, warming effect is produced within the irradiated tissue, but without causing tissue damage by thermal overheating. The method of using a low level reactive laser system from 100 milliwatts per square centimeter to 1000 milliwatts per square centimeter in either a pulsed or continuous mode with optical energy produced by a nd:yag laser at a fundamental wavelength of 1,064 nanometers has been found to reduce pain in soft tissues, reduce inflammation and enhance the healing of tissue by stimulation of microcirculation without subjecting the living tissue to damaging thermal effects. The energy density of the irradiated tissue is limited to the range of from about.1 joule per square centimeter to about 15 joules per square centimeter. An alternative method produces optical energy by an nd:ylf laser at a wavelength of 1,055 nanometers. Other lasers could be used which would produce optical energy in a preferred range of from about 950 to about 1,200 nanometers at the desired power range.
Patent IL-61698-A0 (IL)
Title: Basic ethers,pharmaceutical formulations containing them and a process for their preparation
IPC: C07D311/58
Filed: 1980-12-12
Abstract: Basic ethers of the formula   <IMAGE>   wherein Z is CH3-NR2-CH2CH2-CHR1-, (1-R2-3-piperidyl)-CHR3-, (1-R2-2-piperidyl)-CH2-CHR3- or 1-R2-3-R4-hexahydroazepinyl; R1 is cyclopropyl or Ar; R2 is H, alkyl of 1-4 C atoms, alkenyl of 2-4 C atoms, cycloalkylalkyl of 4-8 C atoms or benzyl; R3 is H or Ar; R4 is H or alkyl of 1-4 C atoms, Y is -O-CHQ1-CHQ2-CH2-, -O-CHQ1-CHQ2-CO-, -O-CQ1=CQ2-CO- or -CH2-CHQ1-CHQ2-CO-; Q1 and Q2 are independently each H, alkyl of 1-4 C atoms, cycloalkyl or alkylcycloalkyl each of 3-6 total C atoms or Ar; and Ar is phenyl or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF3; with the proviso that when Z is (CH3)2N-CH2CH2-CHR1 in 7-position and Y is -O-C(C6H5)=CH-CO- or -O-C(C6H5)=C(CH3)-CO-, R1 is cyclopropyl, or phenyl substituted by F, Cl, alkoxy or alkylthio, each of 1-4 C atoms, methylenedioxy or CF3; or a physiologically acceptable acid addition salt thereof, have valuable pharmacological properties, e.g., are antidepressants.
Patent IL-76652-A0 (IL)
Title: Thiadiazole derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/433
Filed: 1985-10-10
Abstract: The invention relates to thiadiazole derivatives corresponding to the formula:    <IMAGE>  (I)  in which R represents: a linear or branched alkyl group having from 1 to 5 carbon atoms; a cycloalkyl group having 5 or 6 carbon atoms; a phenyl group optionally substituted by 1 or 2 halogen atoms, preferably chlorine, by 1 or 2 lower alkyl or lower alkoxy groups, by 1 or 2 hydroxyl groups or by a nitro or trifluoromethyl group; a biphenylyl group; or an alpha-naphthyl group; and the pharmaceutically acceptable salts of the said derivatives. It also relates to a process for the preparation of the said derivatives and the pharmaceutical compositions in which they are present. The said derivatives act on the central nervous system.
Patent IL-86341-A0 (IL)
Title: Preparation of polychloropyridine derivatives
IPC: C07D213/64
Filed: 1988-05-11
Abstract: Novel aryl and heteroaryl 4-cyano-2,2,4-trichlorobutyrates are prepared by reacting a corresponding aryl or heteroaryl trichloroacetate with acrylonitrile in the presence of a catalyst. Also provided is a novel process for producing 3,5,6-trichloropyridin-2-ol comprising cyclization of an aryl or heteroaryl 4-cyano-2,2,4-trichlorobutyrate in an inert organic solvent at elevated temperatures, in the presence of anhydrous hydrogen chloride.
Patent IL-91781-A0 (IL)
Title: Enrichment and concentration of proteins by ultrafiltration
IPC: A23C9/142
Filed: 1989-09-26
Abstract: Disclosed are ultrafiltration processes for the enrichment and concentration of selected proteins from protein containing fluids. Illustratively, IgG is concentrated from whey by means of multiple ultrafiltration "passes", using a metallic oxide ultrafiltration membrane, which are characterized by differing pH's.
Patent IL-94267-A0 (IL)
Title: Compositions for treating skin disorders containing ketoconazole and their preparation
IPC: A61K8/49
Filed: 1990-05-02
Abstract: The use of ketoconazole or a pharmaceutically acceptable acid addition salt thereof for the manufacture of a medicament for topically treating subjects suffering from acne, hyperkeratotic dermatoses and photo-aging of the skin. Compositions comprising ketoconazole and a retinoid and a process for preparing such compositions.
Patent AU-PQ189499-A0 (AU)
Title: Improvements in or relating to vehicles
IPC: F41H3/00
Filed: 1999-07-28
Abstract: The radar signature of a vessel is reduced by retrofitting it with an array (10) of elements (15) fastened to surfaces (14b) of the vessel. The elements (15) have planar faces (11-12) so oriented that incident radar signal (20) is reflected away from its angle of incidence.
Patent FI-20001677-A0 (FI)
Inventor: TUOMI JOUNI
IPC: F16K27/02
Filed: 2000-07-17
Abstract: The invention relates to a damper in an air conditioning system, comprising a casing part (1) which has a turnable blade (2), which is turnable between an open and a closed position, whereby the blade (2) is in its closed position arranged against a stop part (4) on the inner surface (3) of the casing part (1). The stop part (4) is formed of the inner surface (3) of the casing part (1). An advantage of the damper according to the invention is that it has fewer parts than a conventional damper. Further, it can be manufactured with a smaller number of steps.
Patent FI-20011131-A0 (FI)
Inventor: LE NY CORINNE
IPC: D21F1/66
Filed: 2001-05-30
Abstract: The present invention relates a method for the treating of circulation waters in papermaking processes wherein a stream of process water separated from an aqueous cellulosic pulp suspension of the papermaking process is provided, said separated process water having an elevated level of free calcium ions. A pH of not less than pH 9 is provided in the process water. Gaseous carbon dioxide is distributed in the process water in an amount sufficient for precipitating a substantial part of the calcium ions as solid calcium carbonate in the water and for obtaining a decreased level of free calcium ions in the water. The calcium ion depleted process water is returned to the papermaking process, thereby reducing or preventing the accumulation of calcium ions circulating in the process.
Patent FI-20021431-A0 (FI)
Inventor: REPO HARRI
IPC: C10M159/04
Filed: 2002-08-01
Abstract: The invention relates to a lubricating oil, which is used in the food industry as the oil for, slicers and dividers, as lubricating oil for moulds and pans, or as a pan washing oil. The lubricating oil contains at least -turnip rapeseed oil or rapeseed oil as a main component, -auxiliary lubricant, which is selected from the following agents: -pharmaceutical grade white oil, -methyl ester (RME), ethyl ester (REE) or propyl ester (RPE) of turnip rapeseed oil or rapeseed oil, -emulsifier, which is selected from the following agents: -lecithin -acetic acid esters of mono- and diglycerides of fatty acids, -sucrose esters of fatty acids, -antioxidant, which is added synthetic tocopherol.
Patent IL-105808-A0 (IL)
Title: Apparatus and method for the reduction of snoring
IPC: A61F5/56
Filed: 1993-05-25
Abstract: An apparatus for intra-oral use including a framework having a upper curved platform (12) and a lower curved platform (14), each of the platforms being defined by two walls extending from and separated by a floor, a material bonded to the upper and lower curved platform adapted to be molded in a shape suitable for relatively snugly receiving maxillary teeth (100) of a user and for relatively loosely receiving mandibular teeth (102) of the user when the user's mouth is closed in a normal closing arch, and a cavity (32) formed between the upper and lower platforms adapted to receive the tongue of the user. <IMAGE>
Patent IL-116907-A0 (IL)
Title: Substituted phenyl compounds
IPC: C07D405/12
Filed: 1996-01-25
Abstract: Compounds of formula (I) are described, wherein: R<1> is CN, CH2CN, CH=CHCN, CHO, or CH=CHCO2H; R<2> is aryl lower alkoxy, heteroaryl lower alkoxy, aryl lower alkylthio or heteroaryl lower alkylthio in which each of the aryl and heteroaryl moieties is optionally substituted; R<3> is halogen; R<4> is optionally substituted aryl or optionally substituted heteroaryl; R<5> is carboxy or an acid isostere; X is oxygen or sulphur; and n is zero or 1; and their N-oxides and prodrugs, and pharmaceutically acceptable salts thereof. The compounds have endothelin antagonist activity and are useful as pharmaceuticals.
Patent IL-127026-A0 (IL)
Title: Process for the resolution of racemic ketamine
IPC: C07C225/20
Filed: 1997-05-07
Abstract: PCT No. PCT/EP97/02360 Sec. 371 Date Nov. 10, 1998 Sec. 102(e) Date Nov. 10, 1998 PCT Filed May 7, 1997 PCT Pub. No. WO97/43244 PCT Pub. Date Nov. 20, 1997The present invention is concerned with an improved process for the resolution of racemic 2-(o-chlorophenyl)-2-methylaminocyclohexanone (ketamine).
Patent IL-129649-A0 (IL)
Title: Adhesives with low level of residual monomers and process for manufacturing same
IPC: A61K9/06
Filed: 1997-10-14
Abstract: An adhesive, which contains olefinic polymers and less than 1 % by weight of free monomers, is manufactured via catalytic hydrogenation. It is preferably used in the area of cosmetics, in the food sector, in medicinal plasters and transdermal systems.
Patent IL-135510-A0 (IL)
Title: Improved coding scheme for cable modems
IPC: H04L27/36
Filed: 2000-04-06
Abstract: A modem (12), for use in a cable television network, including a least-significant bit (rate 4/5) convolutional coding scheme is disclosed. In the transmit side of the modem (12), an encoder (28) is included, within which convolutional coders (35I,35Q) are used to each encode one bit of each symbol applied to a QAM phase and amplitude modulation constellation of size sixteen, preferably the least significant bits, such that the encoded bits select one of a plurality of sub-constellations in the modulated signal. Each of the coders (35,35') are arranged as finite state machines, of either thirty-two or sixty-four states. The minimum Hamming distance (dfree) provided by the codes is four, such that the resulting coding gain of the modem is improved over conventional encoding schemes.  <IMAGE>
Patent IL-136040-A0 (IL)
Title: Rotary rolled coin dispenser
IPC: G07D1/00
Filed: 1998-08-03
Abstract: The present invention is an automatic banking system including a cash dispenser and a rolled coin dispenser in a single apparatus. The rolled coin dispensing apparatus includes a rotatable dispensing wheel that holds coin rolls, a rotary drive mechanism for rotating the dispensing wheel to a dispense position, and an ejecting mechanism for ejecting a predetermined number of coin rolls from the dispensing wheel. The dispensing wheel has outer and inner wheel structures that support divider members which receive rolled coin cassettes therebetween. The ejecting mechanism includes pusher arms arranged exteriorly of each dispensing wheel and ejector bars, fixed to each arm, that are located interiorly of the outer wheel structure to be pushed into a cassette disposed at the dispense position to obtain coin rolls therefrom. The ejector bars and cassette located at the dispense position are arranged nonradially with respect to the axial center of their cassette wheel.
Patent IL-137623-A0 (IL)
Title: Method for improving fuel efficiency in combustion chambers
IPC: F02D19/12
Filed: 2000-08-01
Abstract: A method of improving fuel efficiency in combustion chamber, for simultaneously enhancing combustion of hydrocarbon fuels while inhibiting nitrogen oxidation. A mixture of metallic compounds is introduced into the flame zone of a combustion chamber, such that this mixture is held by gases in the flame zone during the combustion of the fuel, and the mixture is thereby ionized prior to or during the combustion. The ionized mixture of compounds contains platinum, rhodium, rhenium, and molybdenum.
Patent IL-140581-A0 (IL)
Title: Bispiperidines as antithrombotic agents
IPC: A61K31/454
Filed: 1999-07-16
Abstract: Novel compounds which are inhibitors of the binding of fibrinogen to the Gp IIb/IIIa platelet receptors, and which can be used therepeutically as antithrombotic agents
Patent IL-147407-A0 (IL)
Title: Local area network for distributing data communication, sensing and control signals
IPC: H04L12/42
Filed: 2000-07-03
Abstract: A device for carrying a power signal and a serial digital data signal over a cable comprises a connector for connecting to the cable; a splitter having first, second and third ports, the splitter being configured so that the power signal is passed from the first port to the second port, and the digital data signal is passed between the first and third ports; a transceiver coupled to the third port of the splitter for point-to-point communication of the full duplex serial digital data signal over the cable; a power supply for voltage conversion coupled to and powered from the second port of the splitter, the power supply having a power source port connected to the transceiver for powering the transceiver from the power supply; a data port coupled to the transceiver and connectable to a data unit for connecting the digital data signal to the data unit; and an indicator powered by the power supply for indicating a status of the device status.
Patent IL-152619-A0 (IL)
Title: Eggs with balanced lipid composition
IPC: A23L15/00
Filed: 2001-05-15
Abstract: The present invention is related to an egg obtained from a domesticated bird, in particular a layer, having a lipid fraction balanced in seeds and green plant-type  omega 6 and  omega 3 fatty acids according to the ratio of seeds and green plant-type  omega 6 fatty acids / seeds and green plant-type  omega 3 fatty acids = 1:1 +/- 10% and having a lipid fraction is balanced between polyunsaturated and saturated fatty acids according to the ratio of polyunsaturated / saturated fatty acids = 1:1 +/- 10%. The present invention is also related to a feed composition of exclusive vegetarian origin and suitable for poultry and a method for obtaining such egg from said poultry animals.
Patent IL-160690-A0 (IL)
Title: Benzothiazepine ileal bile acid transport inhibitors
IPC: A61P9/04
Filed: 2002-09-05
Abstract: The present invention relates to compounds of formula (I) wherein variable groups are as defined within; pharmaceutically acceptable salts, solvates, solvates of such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described
Patent IL-177408-A0 (IL)
Title: Apparatus and method for therapeutic delivery of medication
IPC: A61M5/172
Filed: 2006-08-10
Abstract: A controller for a programmable medical pump is configured to select a drug library file that corresponds to a received medication name and determine a number of times status information is received within a designated time period from a current time during an infusion therapy. The example controller is also configured to determine if the number of times the status information is received comports with an accumulated medication dosage limit using a dose per administration program parameter. Responsive to the number of times the status information is received matching or exceeding the accumulated medication dosage limit, the controller is configured to prevent another administration of the medication until enough time has passed such that the number of times the status information has been received within the designated time period from the current time is less than the accumulated medication dosage limit.
Patent IL-184686-A0 (IL)
Title: Processes for producing 1,2-dihydropyridine derivatives
IPC: C07D413/14
Filed: 2007-07-18
Abstract: The present invention provides compounds represented by the formula:   
or a salt thereof, wherein, each A 1a  and A 3a  are the same as or different from each other and each indicates an optionally substituted C 6-14  aromatic hydrocarbocyclic group or 5 to 14-membered aromatic heterocyclic group; and W represents a halogen atom. The compounds are intermediates for the preparation of inhibitors of the AMPA receptor.
Patent IL-185013-A0 (IL)
Title: Preparation of high purity substituted quinoxaline
Filed: 2007-08-02
Abstract: The present invention comprises an improved process for the preparation of substituted quinoxaline I by cyclization of the corresponding dianiline.
Patent IL-188815-A0 (IL)
Title: Identification device for optical reading and radio frequency encoding adaptable in identification label printer output
Filed: 2008-01-16
Abstract: The invention concerns a device ( 10 ) featuring an optical reader ( 12 ) for printed codes capable of transforming the information of a code printed on an object such as a label into digital data, the object being equipped with a radiofrequency system featuring an antenna ( 27 ) and a chip ( 28 ) connected together. According to a main characteristic of the invention, the device features a radiofrequency dialog unit ( 15 ) designed to encode the chip ( 28 ) with digital data read from the printed code and to compare the digital data encoded in the chip with information from the printed code.